- Branson’s Virgin Galactic takes another step toward space tourism
- Trump’s economy ‘a little under’ 3 percent growth goal: Fed
- As tensions over aid rise, Venezuelan troops fire on villagers, kill two
- Virgin Galactic astronauts describe 'surreal' spaceflight: 'The views are absolutely extraordinary'
- Elementary school teacher captures two students slow dancing on Valentine's Day
A CVS Pharmacy store is seen in the Manhattan borough of New York City, New York, U.S., November 30, 2017. REUTERS/Shannon Stapleton
July 12, 2018
(Reuters) – Shares of CVS Health Corp <CVS.N> and health insurer Aetna Inc <AET.N> rose more than 2 percent on Thursday after CNBC reported that the U.S. Justice Department will not challenge their planned merger.
CNBC said https://www.cnbc.com/2018/07/12/cvs-aetna-shares-rise-on-report-doj-wont-challenge-their-merger-deal.html Bloomberg reported the news, citing trade publication Reorg Research.
CVS Health Corp and Aetna announced the $69 billion deal on Dec. 3 last year, arguing it would enable the companies to tackle soaring healthcare spending by offering lower-cost medical services in pharmacies.
Aetna and CVS declined to comment.
(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)